These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3021320)

  • 1. Detection of bone marrow relapse in patients with small cell carcinoma of the lung.
    Kristjansen PE; Osterlind K; Hansen M
    Cancer; 1986 Dec; 58(11):2538-41. PubMed ID: 3021320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow examination in small cell lung cancer--when is it indicated?
    Feliu J; González Barón M; Artal A; Ordóñez A; Cebreiros I; Martín G; Garrido P; Chacón I; Montero García JM
    Acta Oncol; 1991; 30(5):587-91. PubMed ID: 1654064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of three biochemical markers for serially monitoring the therapy of small-cell lung cancer.
    Ganz PA; Ma PY; Wang HJ; Elashoff RM
    J Clin Oncol; 1987 Mar; 5(3):472-9. PubMed ID: 3029340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactate dehydrogenase values and bone scans as predictors of bone marrow involvement in small-cell lung cancer.
    Hamrick RM; Murgo AJ
    Arch Intern Med; 1987 Jun; 147(6):1070-1. PubMed ID: 3036032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frequency of bone marrow involvement in patients with small cell lung carcinoma before treatment based on selected laboratory parameters].
    Zych J; Polowiec Z; Broniek A; Styszewska H; Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 1993; 61(9-10):481-8. PubMed ID: 8111324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer.
    de Campos E; Radford J; Steward W; Milroy R; Dougal M; Swindell R; Testa N; Thatcher N
    J Clin Oncol; 1995 Jul; 13(7):1623-31. PubMed ID: 7602351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myelotoxicity due to cancer chemotherapy].
    Nakamura S; Yoshida T; Ohtake S; Itoh K; Kobayashi K; Nakanishi J; Matsuda T; Natori H; Egami K
    Nihon Gan Chiryo Gakkai Shi; 1986 Oct; 21(9):2196-205. PubMed ID: 3029252
    [No Abstract]   [Full Text] [Related]  

  • 8. Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
    Johnson DH; Wolff SN; Hainsworth JD; Porter LL; Grosh WW; Hande KR; Greco FA
    J Clin Oncol; 1985 Feb; 3(2):170-5. PubMed ID: 2981981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone evaluation in microcellular cancer treated by chemotherapy].
    Seigneur J; Albrecht N; Feintrenie X; Chambre JF; Lamy P
    Rev Pneumol Clin; 1985; 41(6):365-74. PubMed ID: 3010429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose chemotherapy with autologous bone marrow rescue in small cell lung cancer.
    Wilson C; Pickering D; Stewart S; Vallis K; Kalofonos H; Cross A; Snook D; Goldman JM; McKenzie CG; Epenetos AA
    In Vivo; 1988; 2(5):331-4. PubMed ID: 2856521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged administration of oral etoposide plus cisplatin in extensive stage small cell lung cancer.
    Greco FA; Murphy PB; Hainsworth JD; Hande KR; Johnson DH
    Oncology; 1992; 49 Suppl 1():34-8; discussion 39. PubMed ID: 1323810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of zoledronic acid combined with chemotherapy in treatment of skeletal metastases of non-small cell lung cancer and the bone metabolic markers].
    Hu XY; Zou QF; Jin C; Li WD; Chen WS; Ma L
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1343-6. PubMed ID: 20584674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group.
    Work E; Nielsen OS; Bentzen SM; Fode K; Palshof T
    J Clin Oncol; 1997 Sep; 15(9):3030-7. PubMed ID: 9294465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of bone marrow biopsy specimens and staging of small cell lung cancer.
    ten Velde GP; Kuypers-Engelen BT; Volovics A; Bosman FT
    Eur J Cancer; 1990; 26(11-12):1142-5. PubMed ID: 1963546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow involvement in small cell lung cancer. Clinical significance and correlation with routine laboratory variables.
    Tritz DB; Doll DC; Ringenberg QS; Anderson S; Madsen R; Perry MC; Yarbro JW
    Cancer; 1989 Feb; 63(4):763-6. PubMed ID: 2536586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Circulating hematopoietic stem cells in patients with small cell lung cancer].
    Shimizu E; Mukai J; Nakamura Y; Nakanishi M; Sone S; Ogura T; Takaue Y; Watanabe T; Kawano Y
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3499-501. PubMed ID: 2552933
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
    Lim SC; Park KO; Kim YC; Na KJ; Song H; Bom HS
    Cancer Biother Radiopharm; 2000 Aug; 15(4):381-6. PubMed ID: 11041023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic value of pretreatment serum LDH in patients with limited disease small-cell lung carcinoma.
    Stokkel MP; Van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
    Int J Biol Markers; 1997; 12(4):162-7. PubMed ID: 9582606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
    Miller AA; Rosner GL; Ratain MJ; Hollis DR; Green MR; Schilsky RL
    Clin Cancer Res; 1997 May; 3(5):719-25. PubMed ID: 9815741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.